Healthcare stocks were trading in the positive zone, with the S&P BSE Healthcare index rising 263.67 points or 1.06% at 25160.96 at 09:50 IST.
Among the components of the S&P BSE Healthcare index, Laurus Labs Ltd (up 4.15%), Take Solutions Ltd (up 4.08%),Vimta Labs Ltd (up 3.67%),Dr Lal Pathlabs Ltd (up 2.85%),RPG Life Sciences Ltd (up 2.56%), were the top gainers. Among the other gainers were Max Healthcare Institute Ltd (up 2.55%), Dishman Carbogen Amcis Ltd (up 2.53%), Sun Pharma Advanced Research Company Ltd (up 2.44%), Divis Laboratories Ltd (up 2.26%), and Thyrocare Technologies Ltd (up 2.12%).
On the other hand, Indraprastha Medical Corporation Ltd (down 2.63%), Panacea Biotec Ltd (down 1.69%), and Novartis India Ltd (down 0.86%) moved lower.
At 09:50 IST, the S&P BSE Sensex was up 177.31 or 0.34% at 52118.95.
The Nifty 50 index was up 62.25 points or 0.4% at 15697.6.
The S&P BSE Small-Cap index was up 320.51 points or 1.3% at 24912.12.
The S&P BSE 150 Midcap Index index was up 82.58 points or 1.06% at 7862.26.
On BSE,2074 shares were trading in green, 483 were trading in red and 76 were unchanged.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU